Malaria chemoprophylaxis: Strategies for risk groups

Clinical Microbiology Reviews

Volumn 21, Issue 3, 2008, Pages 466-472

  Schlagenhauf, Patricia ^a   Petersen, Eskild ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CHLOROQUINE PLUS PROGUANIL; DOXYCYCLINE; FANSIDAR; INSECT REPELLENT; MEFLOQUINE; PRIMAQUINE; PROGUANIL; QUININE;

ADJUVANT THERAPY; BREAST FEEDING; CHEMOPROPHYLAXIS; CHILD HEALTH; CLINICAL TRIAL; ENDEMIC DISEASE; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; INCIDENCE; MALARIA; MONOTHERAPY; MORBIDITY; MORTALITY; PLASMODIUM OVALE; PLASMODIUM VIVAX; PREGNANT WOMAN; PREVENTION AND CONTROL; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; TRAVEL; TREATMENT CONTRAINDICATION; UNSPECIFIED SIDE EFFECT; VAGINA CANDIDIASIS;

ANIMALS; ANTIMALARIALS; BREAST FEEDING; CHEMOPREVENTION; CHILD; FEMALE; HUMANS; MALARIA; PREGNANCY; RISK ASSESSMENT; TIME FACTORS; TRAVEL;

PLASMODIUM FALCIPARUM; PLASMODIUM OVALE; PLASMODIUM VIVAX;

EID: 47949101185     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00059-07     Document Type: Review

References (40)

1. Arguin, P., and P. Schlagenhauf. 2008. Malaria deaths in travelers, p. 323-331. In P. Schlagenhauf-Lawlor (ed.), Travelers' malaria, 2nd ed. BC Decker, Hamilton, Ontario, Canada.
2. Askling, H. H., J. Nilsson, A. Tegnell, R. Janzon, and K. Ekdahl. 2005. Malaria risk in travelers. Emerg. Infect. Dis. 11:436-441.
3. Baird, J. K., H. Basri, Purnomo, M. J. Bangs, B. Subianto, L. C. Patchen, and S. L. Hoffman. 1991. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 44:547-552.
4. Behrens, R. H., B. Carroll, J. Beran, O. Bouchaud, U. Hellgren, C. Hatz, T. Jelinek, F. Legros, N. Mühlberger, B. Myrvang, H. Siikamäki, L. Visser, et al. 2007. The low and declining risk of malaria in travellers to Latin America: is there still an indication for chemoprophylaxis? Malar. J. 6:114.
5. Bottieau, E., J. Clerinx, E. Van Den Enden, M. Van Esbroeck, R. Colebunders, A. Van Gompel, and J. Van Den Ende. 2006. Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Am. J. Trop. Med. Hyg. 75:133-138.
6. CDC. 2007. Travellers health, yellow book 2007. CDC, Atlanta, GA. www.cdc.gov.
7. Chen, L. H., and J. S. Keystone. 2005. New strategies for the prevention of malaria in travelers. Infect. Dis. Clin. N. Am. 19:185-210.
8. Chen, L. H., M. E. Wilson, and P. Schlagenhauf. 2006. Prevention of malaria in long-term travelers. JAMA 296:2234-2244.
9. Chen, L. H., M. E. Wilson, and P. Schlagenhauf. 2007. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA 297:2251-2263.
10. Dellicour, S., S. Hall, D. Chandramohan, and B. Greenwood. 2007. The safety of artemisinins during pregnancy: a pressing question. Malar. J. 6:15.
11. Desai, M., F. O. ter Kuile, F. Nosten, R. McGready, K. Asamoa, B. Brabin, and R. D. Newman. 2007. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 7:93-104.
12. Elliott, J. H., D. O'Brien, K. Leder, S. Kitchener, E. Schwartz, L. Weld, G. V. Brown, K. C. Kain, J. Torresi, et al. 2004. Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers. J. Travel Med. 11:213-217.
13. Genderen, P. J., H. R. vanKoene, K. Spong, and D. Overbosch. 2007. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of Plasmodium falciparum malaria in non-immune travelers and expatriates. J. Travel Med. 14:92-95.
14. Hellgren, U., V. H. Angel, Y. Bergqvist, J. S. Forero-Gomez, and L. Rombo. 1991. Plasma concentrations of sulfadoxine-pyrimethamine, mefloquine and its main metabolite after regular malaria prophylaxis for two years. Trans. R. Soc. Trop. Med. Hyg. 85:356-357.
15. Hill, D. R., J. K. Baird, M. E. Parise, L. S. Lewis, E. T. Ryan, and A. J. Magill. 2006. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am. J. Trop. Med. Hyg. 75:402-415.
16. Jelinek, T., R. Behrens, Z. Bisoffi, A. Bjorkmann, J. Gascon, U. Hellgren, E. Petersen, T. Zoller, R. H. Andersen, A. Blaxhult, et al. 2007. Recent cases of falciparum malaria imported to Europe from Goa, India, December 2006-January 2007. Eur. Surveill. 12:E070111.1.
17. Kofoed, K., and E. Petersen. 2003. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine and atovaquone plus proguanil in travellers from Denmark. J. Travel Med. 10:150-154.
18. Lengeler, C. 2004. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst. Rev. 2:CD000363.
19. Marbiah, N. T., E. Petersen, K. David, J. Lines, E. Magbity, and D. B. Bradley. 1998. Control of clinical malaria due to Plasmodium falciparum in children in an area of rural Sierra Leone with perennial transmission: a community-wide trial of lambdacyhalothrin-impregnated mosquito nets alone and/or with fortnightly dapsone/pyrimethamine/placebo chemoprophylaxis. Am. J. Trop. Med. Hyg. 58:1-6.
20. McGready, R., E. A. Ashley, and F. Nosten. 2004. Malaria and the pregnant traveller. Travel Med. Infect. Dis. 2:127-142.
21. Mendis, K., B. J. Sina, P. Marchesini, and R. Carter. 2001. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64(1-2 Suppl):97-106.
22. Msyamboza, K., E. Senga, E. Tetteh-Ashong, P. Kazembe, and B. J. Brabin. 2007. Estimation of effectiveness of interventions for malaria control in pregnancy using the screening method. Int. J. Epidemiol. 36:406-411.
23. Mühlberger, N., T. Jelinek, J. Gascon, M. Probst, T. Zoller, M. Schunk, et al. 2004. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar. J. 3:5.
24. Osei-Akoto, A., L. Orton, and S. P. Owusu-Ofori. 2005. Atovaquone-proguanil for treating uncomplicated malaria. Cochrane Database Syst. Rev. 4:CD004529.
25. Phillips-Howard, P. A., A. Radalowicz, J. Mitchell, and D. J. Bradley. 1990. Risk of malaria in British residents returning from malarious areas. Br. Med. J. 300:499-503.
26. Pukrittayakamee, S., M. Imwong, S. Looareesuwan, and N. J. White. 2004. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop. 89:351-356.
27. Rodriguez-Morales, A. J., E. Sanchez, M. Vargas, C. Piccolo, R. Colina, M. Arria, and C. Franco-Paredes. 2006. Pregnancy outcomes associated with Plasmodium vivax malaria in northeastern Venezuela. Am. J. Trop. Med. Hyg. 74:755-757.
28. Schlagenhauf, P. (ed.). 2008. Travelers' malaria, p. 1-9, 2nd ed. BC Decker, Hamilton, Ontario, Canada.
29. Schlagenhauf, P., A. Tschopp, R. Johnson, H. D. Nothdurft, B. Beck, E. Schwartz, M. Herold, B. Krebs, O. Veit, R. Allwinn, and R. Steffen. 2003. Tolerability of malaria chemoprophylaxis in non-immune travellers to subSaharan Africa: multicentre, randomised, double blind, four arm study. BMJ 327:1078-1085.
30. Schlagenhauf, P., and M. Funk-Baumann. 2005. PDQ travellers malaria. BC Decker, London, United Kingdom.
31. Schlagenhauf, P. 2007. Pregnant? Breastfeeding? Traveling with infants? Malaria prevention challenges for mothers, abstr. PL03.03 P34. Abstr. Proc. 10th Conf. Int. Soc. Travel Med., Vancouver, Canada, 20 to 24 May 2007.
32. Schwartz, E., and G. Regev-Yochay. 1999. Primaquine as prophylaxis for malaria for nonimmune travelers: a comparison with mefloquine and doxycycline. Clin. Infect. Dis. 29:1502-1506.
33. Schwartz, I. K., E. M. Lackritz, and L. C. Patchen. 1991. Chloroquine-resistant Plasmodium vivax from Indonesia. N. Engl. J. Med. 324:927.
34. Sonmez, A., A. Harlak, S. Kilic, Z. Polat, L. Hayat, O. Keskin, T. Dogru, M. I. Yilmaz, C. H. Acikel, and I. H. Kocar. 2005. The efficacy and tolerability of doxycyclinc and mefloquine in malaria prophylaxis of the ISAF troops in Afghanistan. J. Infect. 51:253-258.
35. Spudick, J. M., L. S. Garcia, D. M. Graham, and D. A. Haake. 2005. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax. J. Clin. Microbiol. 43:978-981.
36. Swales, C. A., P. L. Chiodini, B. A. Bannister, et al. 2007. New guidelines on malaria prevention: a summary. J. Infect. 54:107-110.
37. Toovey, S., F. Moerman, and A. van Gompel. 2007. Special infectious disease risks of expatriates and long-term travelers in tropical countries. Part I: malaria. J. Travel Med. 14:42-49.
38. Villegas, L., R. McGready, M. Htway, M. K. Paw, M. Pimanpanarak, R. Arunjerdja, S. J. Viladpai-Nguen, B. Greenwood, N. J. White, and F. Nosten. 2007. Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial. Trop. Med. Int. Health 12:209-218.
39. Wells, T. S., T. C. Smith, B. Smith, L. Z. Wang, C. J. Hansen, R. J. Reed, W. E. Goldfinger, T. E. Corbeil, C. N. Spooner, and M. A. Ryan. 2006. Mefloquine use and hospitalizations among US service members, 2002-2004. Am. J. Trop. Med. Hyg. 74:744-749.
40. WHO. 2007. International travel and health. WHO, Geneva, Switzerland. www.who.int/ITH.